ConductScience.org, home

Paper41244792

Current status, challenges, and integration pathways of biomarker classification systems in graft-versus-host disease: a preliminary exploration.

Yu X and 7 others. Front Med (Lausanne), 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Current status, challenges, and integration pathways of biomarker classification systems in graft-versus-host disease: a preliminary exploration. Papers, record 41244792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41244792

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Current status, challenges, and integration pathways of biomarker classification systems in graft-versus-host disease: a preliminary exploration.
PubMed
Journal
Front Med (Lausanne)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-11-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yu XXinxin
2Huang SShuai
3Li XXiaoxia
4Zhao YYizhuo
5Jin XXiaohan
6Fan MMeiqi
7Zhang YYuanfeng
8Ma LLusheng

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References126

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127217465Biomarker Panel for Chronic Graft-Versus-Host Disease.J Clin Oncol2016https://conductscience.org/library/papers/27217465PubMed
235030629Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease.Blood Adv2022https://conductscience.org/library/papers/35030629PubMed
335634722Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction.Am J Transplant2022https://conductscience.org/library/papers/35634722PubMed
439489917Ex vivo-generated human CD1c+ regulatory B cells by a chemically defined system suppress immune responses and alleviate graft-versus-host disease.Mol Ther2024https://conductscience.org/library/papers/39489917PubMed
538117900Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects.Sci Transl Med2023https://conductscience.org/library/papers/38117900PubMed
628665299Cytokine mediators of chronic graft-versus-host disease.J Clin Invest2017https://conductscience.org/library/papers/28665299PubMed
731406955Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology.JCO Precis Oncol2019https://conductscience.org/library/papers/31406955PubMed
838113462Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.Blood Adv2024https://conductscience.org/library/papers/38113462PubMed
927365424TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment.Blood2016https://conductscience.org/library/papers/27365424PubMed
1032534102Suppression of Hematopoietic Primitive Cells in Patients with Secondary Failure of Platelet Recovery after Acute Graft-versus-Host Disease.Biol Blood Marrow Transplant2020https://conductscience.org/library/papers/32534102PubMed
1138543084Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38543084PubMed
1231434801A panel of 4 biomarkers for the early diagnosis and therapeutic efficacy of aGVHD.JCI Insight2019https://conductscience.org/library/papers/31434801PubMed
1323200544Have we made progress in the treatment of GVHD?Best Pract Res Clin Haematol2012https://conductscience.org/library/papers/23200544PubMed
1437480848Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity.Immunity2023https://conductscience.org/library/papers/37480848PubMed
1529348127Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.Blood2018https://conductscience.org/library/papers/29348127PubMed
1639017661Oral and Gut Microbiome Alterations in Oral Chronic GVHD Disease: Results from Close Assessment and Testing for Chronic GVHD (CATCH Study).Clin Cancer Res2024https://conductscience.org/library/papers/39017661PubMed
1734816294Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy.Ann Hematol2022https://conductscience.org/library/papers/34816294PubMed
1834658668Childhood Allergy Disease, Early Diagnosis, and the Potential of Salivary Protein Biomarkers.Mediators Inflamm2021https://conductscience.org/library/papers/34658668PubMed
1933139661Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome.Int J Mol Sci2020https://conductscience.org/library/papers/33139661PubMed
2030106382Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease.J Clin Invest2018https://conductscience.org/library/papers/30106382PubMed

See all 126 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41244792

GET https://conductscience.org/api/papers/v1/41244792/references?page=2